作者
Camilla Engblom,Christina Pfirschke,Rapolas Žilionis,Janaina Da Silva Martins,Stijn A. Bos,Gabriel Courties,Steffen Rickelt,Nicolas Sévère,Ninib Baryawno,Julien Faget,Virginia Savova,David Zemmour,Jaclyn Kline,Marie Siwicki,Christopher Garris,Ferdinando Pucci,Hsin-Wei Liao,Yi-Jang Lin,Andita Newton,Omar Yaghi,Yoshiko Iwamoto,Benoit Tricot,Gregory R. Wojtkiewicz,Matthias Nahrendorf,Virna Cortez‐Retamozo,Etienne Meylan,Richard O. Hynes,Marie B. Demay,Allon M. Klein,Miriam A. Bredella,David T. Scadden,Ralph Weissleder,Mikaël J. Pittet
摘要
A bona fide portrayal of tumor growth Bone has a well-established role in advanced cancer. It provides a supportive microenvironment for the growth of metastatic cells that escape the primary tumor, which ultimately leads to loss of bone mass. Engblom et al. show that bone may also contribute to early-stage tumorigenesis through a mechanism that leads to an increase in bone mass (see the Perspective by Zhang and Lyden). In mouse models of lung adenocarcinoma, primary tumor cells remotely activated bone-resident cells called osteoblasts, which have a bone-building function. The activated osteoblasts in turn triggered production of a certain type of neutrophil that infiltrates the primary tumor and promotes its growth. Patients with early-stage lung cancer were also found to have an increase in bone density, consistent with the findings in mice. Science , this issue p. eaal5081 ; see also p. 1127